Timmerman RD - Search Results

1

A Randomized, Phase III Study of Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) in High-Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC).

Teke ME, Sarvestani AL, Hernandez JM, Fernando HC, Timmerman RD. Teke ME, et al. Among authors: timmerman rd. Ann Surg Oncol. 2022 Aug;29(8):4686-4687. doi: 10.1245/s10434-022-11584-3. Epub 2022 May 6. Ann Surg Oncol. 2022. PMID: 35524087 Clinical Trial. No abstract available.

2

Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer.

Timmerman R, McGarry R, Yiannoutsos C, Papiez L, Tudor K, DeLuca J, Ewing M, Abdulrahman R, DesRosiers C, Williams M, Fletcher J. Timmerman R, et al. J Clin Oncol. 2006 Oct 20;24(30):4833-9. doi: 10.1200/JCO.2006.07.5937. J Clin Oncol. 2006. PMID: 17050868 Clinical Trial.

3

Stereotactic body radiation therapy in multiple organ sites.

Timmerman RD, Kavanagh BD, Cho LC, Papiez L, Xing L. Timmerman RD, et al. J Clin Oncol. 2007 Mar 10;25(8):947-52. doi: 10.1200/JCO.2006.09.7469. J Clin Oncol. 2007. PMID: 17350943 Review.

4

The North American experience with stereotactic body radiation therapy in non-small cell lung cancer.

Timmerman RD, Park C, Kavanagh BD. Timmerman RD, et al. J Thorac Oncol. 2007 Jul;2(7 Suppl 3):S101-12. doi: 10.1097/JTO.0b013e318074e4fa. J Thorac Oncol. 2007. PMID: 17603304 Free article.

5

Baseline pulmonary function as a predictor for survival and decline in pulmonary function over time in patients undergoing stereotactic body radiotherapy for the treatment of stage I non-small-cell lung cancer.

Henderson M, McGarry R, Yiannoutsos C, Fakiris A, Hoopes D, Williams M, Timmerman R. Henderson M, et al. Int J Radiat Oncol Biol Phys. 2008 Oct 1;72(2):404-9. doi: 10.1016/j.ijrobp.2007.12.051. Epub 2008 Apr 18. Int J Radiat Oncol Biol Phys. 2008. PMID: 18394819 Clinical Trial.

6

Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable stage I-II non-small-cell lung cancer.

Xiao Y, Papiez L, Paulus R, Timmerman R, Straube WL, Bosch WR, Michalski J, Galvin JM. Xiao Y, et al. Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1235-42. doi: 10.1016/j.ijrobp.2008.11.019. Int J Radiat Oncol Biol Phys. 2009. PMID: 19251095 Free PMC article.

7

Stereotactic body radiation therapy for inoperable early stage lung cancer.

Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, Fakiris A, Bezjak A, Videtic G, Johnstone D, Fowler J, Gore E, Choy H. Timmerman R, et al. JAMA. 2010 Mar 17;303(11):1070-6. doi: 10.1001/jama.2010.261. JAMA. 2010. PMID: 20233825 Free PMC article. Clinical Trial.

8

Stereotactic body radiation therapy (stereotactic ablative radiotherapy) for stage I non-small cell lung cancer--updates of radiobiology, techniques, and clinical outcomes.

Hadziahmetovic M, Loo BW, Timmerman RD, Mayr NA, Wang JZ, Huang Z, Grecula JC, Lo SS. Hadziahmetovic M, et al. Among authors: timmerman rd. Discov Med. 2010 May;9(48):411-7. Discov Med. 2010. PMID: 20515609 Free article. Review.

9

Phase I dose-escalation study of stereotactic body radiotherapy in patients with hepatic metastases.

Rule W, Timmerman R, Tong L, Abdulrahman R, Meyer J, Boike T, Schwarz RE, Weatherall P, Chinsoo Cho L. Rule W, et al. Ann Surg Oncol. 2011 Apr;18(4):1081-7. doi: 10.1245/s10434-010-1405-5. Epub 2010 Nov 3. Ann Surg Oncol. 2011. PMID: 21046264 Clinical Trial.

10

From the guest editors: treatment of early-stage lung cancer.

Timmerman RD, Fernando HC. Timmerman RD, et al. Cancer J. 2011 Jan-Feb;17(1):1-2. doi: 10.1097/PPO.0b013e31820e27de. Cancer J. 2011. PMID: 21263259 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

304 results

Search Page